# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001398733-26-000029
Filing Date
2026-05-13
Accepted
2026-05-13 16:04:40
Documents
34
Period of Report
2026-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aqst-20260512.htm iXBRL | 8-K | 56455
2 | EX-99.1 | q12026-ex991earningsrelease.htm | EX-99.1 | 202111
3 | EX-99.2 | debtrefinancepressreleas.htm | EX-99.2 | 9616
4 | EX-99.3 | earningsreleasesupplemen.htm | EX-99.3 | 23250
8 |  | aqstlogo.jpg | GRAPHIC | 14528
9 |  | debtrefinancepressreleas001.jpg | GRAPHIC | 288338
10 |  | debtrefinancepressreleas002.jpg | GRAPHIC | 299716
11 |  | debtrefinancepressreleas003.jpg | GRAPHIC | 75962
12 |  | earningsreleasesupplemen001.jpg | GRAPHIC | 109396
13 |  | earningsreleasesupplemen002.jpg | GRAPHIC | 318181
14 |  | earningsreleasesupplemen003.jpg | GRAPHIC | 150627
15 |  | earningsreleasesupplemen004.jpg | GRAPHIC | 46076
16 |  | earningsreleasesupplemen005.jpg | GRAPHIC | 104358
17 |  | earningsreleasesupplemen006.jpg | GRAPHIC | 111172
18 |  | earningsreleasesupplemen007.jpg | GRAPHIC | 108999
19 |  | earningsreleasesupplemen008.jpg | GRAPHIC | 45502
20 |  | earningsreleasesupplemen009.jpg | GRAPHIC | 101840
21 |  | earningsreleasesupplemen010.jpg | GRAPHIC | 42052
22 |  | earningsreleasesupplemen011.jpg | GRAPHIC | 82630
23 |  | earningsreleasesupplemen012.jpg | GRAPHIC | 42226
24 |  | earningsreleasesupplemen013.jpg | GRAPHIC | 70897
25 |  | earningsreleasesupplemen014.jpg | GRAPHIC | 93687
26 |  | earningsreleasesupplemen015.jpg | GRAPHIC | 62847
27 |  | earningsreleasesupplemen016.jpg | GRAPHIC | 37241
| Complete submission text file | 0001398733-26-000029.txt |  | 3490010

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20260512.xsd | EX-101.SCH | 1776
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20260512_lab.xml | EX-101.LAB | 21629
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20260512_pre.xml | EX-101.PRE | 12504
37 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20260512_htm.xml | XML | 2719

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 26973158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)